845654-02-6

Basic information

• Product Name: (2S)-1-[(2R)-4-Benzoyl-2-methyl-piperazin-1-yl]-2-(quinolin-5-yloxy)-propan-1-one
• Synonyms: (2S)-1-[(2R)-4-Benzoyl-2-methyl-piperazin-1-yl]-2-(quinolin-5-yloxy)-propan-1-one
• CAS NO: 845654-02-6
• Molecular Weight: 403.481
• Mol File: 845654-02-6.mol

Chemical Properties

• CAS DataBase Reference: (2S)-1-[(2R)-4-Benzoyl-2-methyl-piperazin-1-yl]-2-(quinolin-5-yloxy)-propan-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: (2S)-1-[(2R)-4-Benzoyl-2-methyl-piperazin-1-yl]-2-(quinolin-5-yloxy)-propan-1-one(845654-02-6)
• EPA Substance Registry System: (2S)-1-[(2R)-4-Benzoyl-2-methyl-piperazin-1-yl]-2-(quinolin-5-yloxy)-propan-1-one(845654-02-6)

Safety Data

• Hazardous Substances Data: 845654-02-6(Hazardous Substances Data)

Upstream product

• 845776-06-9 C₁₂H₁₁NO₃ 
• 357263-39-9 1-benzoyl-3-(R)-methylpiperazine 
• 845654-94-6 (2S)-2-(quinolin-5-yloxy)-propionic acid sodium salt 

Downstream Products

• 845655-23-4 (2S)-1-[(2R)-4-Benzoyl-2-methyl-piperazin-1-yl]-2-(8-bromo-quinolin-5-yloxy)-propan-1-one 

Relevant articles and documents

Design and optimisation of potent gp120-CD4 inhibitors

The synthesis and structure-activity relationship of a series of novel gp120-CD4 inhibitors are described. Pharmacokinetic studies and antiviral spectrum assessment of lead compounds led to the identification of compound 36, a potent gp120-CD4 inhibitor w

Piperazine derivatives

This invention relates to a compound of formula (I) or pharmaceutically acceptable salts, solvates or derivatives thereof, wherein R1 to R5 are defined in the description, and to processes for the preparation thereof, intermediates used in their preparation, compositions containing them and the uses of such derivatives. The compounds of the present invention inhibit the interaction of gp120 with CD4 and are therefore of use in the treatment of HIV, a retroviral infection genetically related to HIV, or AIDS.